Yahoo Malaysia Web Search

Sign In

Search results

  1. www.youtube.com › watchComedian Amir Gollan, "Last Comic Standing" Semi-finals 2015

    Watch Amir Gollan's hilarious stand-up performance in the semi-finals of Last Comic Standing 2015.

  2. Videos

    View all

  3. www.linkedin.com › in › amir-golan-61673013Amir Golan - EY | LinkedIn

    View Amir Golan’s profile on LinkedIn, a professional community of 1 billion members. Senior Enterprise Risk executive in the Financial Services industry with extensive…

  4. www.youtube.com › watchAmir Golan, CEO of Codeoasis - Sep 2, 2018 - YouTube

    2 Sep 2018 · Amir Golan, CEO of Codeoasis speaking at ILTV studio about an Israeli company Codeoasis that's paving the way for companies to enter the digital age. www.ilt...

  5. Images

    • Amir Golan on LinkedIn: #awsreinvent #microbiome #sciencematters
    • Amir Golan, CEO of Codeoasis - Sep 2, 2018 - YouTube
    • Amir Golan | LinkedIn
    • Amir Golan - CEO - CodeOasis | LinkedIn

    View all

  6. www.youtube.com › watchAmir & Eyal Golan - Tslil Meitar [Le Dôme, Marseille] - YouTube

    2 Feb 2015 · Amir & Eyal Golan - Tslil Meitar [Le Dôme, Marseille] - YouTube. 923K subscribers. Subscribed. 2.2K. 337K views 9 years ago. AMIR – ADDICTIONS Ultime édition disponible, 22 titres – 1 inédits...

  7. www.linkedin.com › in › amir-gollan-48111614Amir Gollan - Writer/Stand-up Comedian - Self Employed - LinkedIn

    View Amir Gollan’s profile on LinkedIn, a professional community of 1 billion members. Comedy · Original “Late Night with Conan O’Brien” monologue joke staff writer.

  8. www.imdb.com › name › nm2155572Amir Golan - IMDb

    Amir Golan is known for Downtown Precinct (2011), Kicking Out Shoshana (2014) and White Panther (2013).

  9. targeted-radiopharma-us.com › speaker › amir-golanAmir Golan - 3rd Targeted Radiopharmaceuticals Summit US 2024

    Amir Golan - 3rd Targeted Radiopharmaceuticals Summit US 2024. Company: Novartis. Job title: Vice President, Radioligand Therapy Platform. Seminars: Panel Discussion: Reflecting on the Past Year- Discussing Current Radiopharmaceutical Trends & Assessing Our Progress 8:30 am.